Seeking Alpha

Acorda Therapeutics Inc. (ACOR)

()

News & PR
Market Currents

Buzz
Twitter: ACOR

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Wall Street Breakfast: Must-Know News
Feb 25 • SA Editor Rachael Granby • ABK, ACOR, AIG • 14 Comments
Why I Doubt the FDA Will Approve Acorda's Fampridine
Apr 24 • Dr. Anthony • ACOR • 12 Comments
A Biotech Bloom in July
Jul 28, 2008 • Option Dragon • ACOR, ALXN, AMGN • 10 Comments
MS Drug Fampridine Sends Acorda Stock Way Up
Jun 3, 2008 • Eben Tessari • ACOR • 9 Comments
9 Possible Pharma Deals for 2009
Jan 8 • Zacks.com • ACOR, AMGN, ARNA • 7 Comments
On Small Cap Drug Makers and Volatility
Oct 18 • Justin M. Hall • ACOR, AGN, SPPI • 6 Comments
Friday Options Recap
Oct 9 • Frederic Ruffy • ACOR, AMSC, C • 5 Comments
Equities: Rally Revives as DJIA Hits Year's Highs
Oct 9 • Midnight Trader • ACOR, AVNR, DB • 5 Comments
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2 • Mark Cifra • ACOR, ARNA, CVTX • 5 Comments
20 Emerging Healthcare Stocks to Watch in '09
Jan 11 • Mike Havrilla • ACOR, AMAG, APPY • 4 Comments
Tuesday's Options Recap
Mar 31 • Frederic Ruffy • AAPL, ACOR, BAC • 4 Comments
Equities Update: Late Rally
Oct 15 • Midnight Trader • ACOR, CIT, HOG • 4 Comments
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
May 27 • Mark Cifra • ACOR, AGN, AMAG • 4 Comments
FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences
Jul 2 • Mike Havrilla • ACOR, DSCO, HGSI • 3 Comments
FDA and Clinical Trial Updates: Weight Loss, Diabetes and More
Apr 2 • Mike Havrilla • ACOR, ARNA, AZN • 3 Comments
FDA Decisions and Clinical Trials: An Updated Calendar
Feb 6 • Mike Havrilla • ACOR, ANPI, BFRM • 2 Comments
Where Might Genentech Investors Redeploy $47B?
Mar 16 • Michael Becker • ACOR, ALXN, AMAG • 2 Comments
Monday Options Update: EWJ, XLF, ACOR, TWC & GE
Feb 2 • Andrew Wilkinson • ACOR, EWJ, GE • 1 Comment
Stage Set for Acorda Bounce?
Oct 11 • M. E. Garza • ACOR, BIIB • 1 Comment
Tuesday Options Recap
Oct 13 • Frederic Ruffy • ABX, ACOR, AKAM • 1 Comment
Positive FDA Panel Outcome for Acorda Therapeutics
Oct 15 • Mike Havrilla • ACOR • 1 Comment
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
Jun 28 • Marco Hickey • ABAX, ACOR, ALKS • 1 Comment

Acorda Therapeutics Inc. (ACOR)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers